JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:398-405, doi:10.1016/j.jacc.2004.01.054
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thaman, R.
Right arrow Articles by Elliott, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thaman, R.
Right arrow Articles by Elliott, P. M.

CLINICAL RESEARCH: HYPERTROPHIC CARDIOMYOPATHY

Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy

Rajesh Thaman, MRCP, MD*{dagger}, Juan R. Gimeno, MD*{dagger}, Sebastian Reith, MD*{dagger}, Maria T. Tome Esteban, MD*{dagger}, Giuseppe Limongelli, MD*{dagger}, Ross T. Murphy, MRCPI, MD*{dagger}, Bryan Mist, PhD*{dagger}, William J. McKenna, MD, FRCP, FESC, FACC*{dagger} and Perry M. Elliott, MD, MRCP, FACC{dagger},*

* Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom
{dagger} The Heart Hospital, University College London, London, United Kingdom

Manuscript received July 24, 2003; revised manuscript received January 21, 2004, accepted January 27, 2004.

* Reprint requests and correspondence: Dr. Perry M. Elliott, The Heart Hospital, 16-18 Westmoreland Street, London W1G 8PH, United Kingdom.
perry.elliott{at}uclh.org

OBJECTIVES: The aim of this study was to determine the natural history of patients with hypertrophic cardiomyopathy (HCM) and severe left ventricular hypertrophy (LVH) (i.e., maximal left ventricular wall thickness [MLVWT] ≥30 mm) and whether changes in cardiac morphology influence the course of the disease.

BACKGROUND: Severe LVH is common in young and rare among elderly patients with HCM. This has been explained by a high incidence of sudden death. We hypothesized that this age-related difference might be explained by left ventricular wall thinning.

METHODS: A total of 106 (age 33 ± 15 years; 71 males) consecutive patients with severe LVH underwent history taking, examination, electrocardiography, echocardiography, cardiopulmonary exercise testing, and Holter analysis. Survival data were collected at subsequent clinic visits or by communication with patients and their general practioners. In order to assess morphologic and functional changes, 71 (67.0%) patients (mean age 31 ± 15 years; 47 males) followed at our institution underwent serial (≥1 year) assessment.

RESULTS: Of the 106 patients, the majority (78 [71.6%]) were <40 years of age. During follow-up (92 ± 50 months [range 1 to 169]), 18 (17.0%) patients died or underwent heart transplantation (13 sudden cardiac deaths, 2 heart failure deaths, 1 heart transplantation, 1 stroke, 1 postoperative death). Five-year survival from sudden death was 90.1% (95% confidence interval [CI] 84.0% to 96.3%), and that from heart failure death or transplantation was 97.7% (95% CI 94.5 to 100). In patients serially evaluated over 85 ± 51 months, there was an overall reduction in MLVWT of 0.6 mm/year (95% CI 0.31 to 0.81, p = 0.00004). Wall thinning ≥5 mm was observed in 41 patients (57.7%; age 35 ± 13 years; 28 males). On multivariate analysis, the follow-up duration only predicted wall thinning (0.6 mm/year, 95% CI 0.38 to 0.85, p < 0.00001).

CONCLUSIONS: Left ventricular remodeling is common in patients with severe LVH and contributes to the low prevalence of severe LVH seen in middle age and beyond.

Abbreviations and Acronyms
  FS = fractional shortening
  HCM = hypertrophic cardiomyopathy
  ICD = implantable cardioverter-defibrillator
  LV = left ventricular
  LVEDD = left ventricular end-diastolic diameter
  LVESD = left ventricular end-systolic diameter
  LVH = left ventricular hypertrophy
  LVOTG = left ventricular outflow tract gradient
  MLVWT = maximal left ventricular wall thickness
  NSVT = nonsustained ventricular tachycardia




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
T. Kubo, H. Kitaoka, M. Okawa, Y. Matsumura, N. Hitomi, N. Yamasaki, T. Furuno, J. Takata, M. Nishinaga, A. Kimura, et al.
Lifelong Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Caused by a Founder Frameshift Deletion Mutation in the Cardiac Myosin-Binding Protein C Gene Among Japanese
J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1737 - 1743.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.